Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 333

1.

The long noncoding RNA CHRF regulates cardiac hypertrophy by targeting miR-489.

Wang K, Liu F, Zhou LY, Long B, Yuan SM, Wang Y, Liu CY, Sun T, Zhang XJ, Li PF.

Circ Res. 2014 Apr 25;114(9):1377-88. doi: 10.1161/CIRCRESAHA.114.302476. Epub 2014 Feb 20.

2.

The H19 long noncoding RNA is a novel negative regulator of cardiomyocyte hypertrophy.

Liu L, An X, Li Z, Song Y, Li L, Zuo S, Liu N, Yang G, Wang H, Cheng X, Zhang Y, Yang X, Wang J.

Cardiovasc Res. 2016 Jul 1;111(1):56-65. doi: 10.1093/cvr/cvw078. Epub 2016 Apr 15.

PMID:
27084844
3.

Cardiac hypertrophy is negatively regulated by miR-541.

Liu F, Li N, Long B, Fan YY, Liu CY, Zhou QY, Murtaza I, Wang K, Li PF.

Cell Death Dis. 2014 Apr 10;5:e1171. doi: 10.1038/cddis.2014.141.

4.

MicroRNA-22 regulates cardiac hypertrophy and remodeling in response to stress.

Huang ZP, Chen J, Seok HY, Zhang Z, Kataoka M, Hu X, Wang DZ.

Circ Res. 2013 Apr 26;112(9):1234-43. doi: 10.1161/CIRCRESAHA.112.300682. Epub 2013 Mar 22.

5.

miR-9 and NFATc3 regulate myocardin in cardiac hypertrophy.

Wang K, Long B, Zhou J, Li PF.

J Biol Chem. 2010 Apr 16;285(16):11903-12. doi: 10.1074/jbc.M109.098004. Epub 2010 Feb 21.

6.

HOTAIR functions as a competing endogenous RNA to regulate PTEN expression by inhibiting miR-19 in cardiac hypertrophy.

Lai Y, He S, Ma L, Lin H, Ren B, Ma J, Zhu X, Zhuang S.

Mol Cell Biochem. 2017 Aug;432(1-2):179-187. doi: 10.1007/s11010-017-3008-y. Epub 2017 Mar 18.

PMID:
28316060
7.

Cardiac hypertrophy is positively regulated by MicroRNA miR-23a.

Wang K, Lin ZQ, Long B, Li JH, Zhou J, Li PF.

J Biol Chem. 2012 Jan 2;287(1):589-99. doi: 10.1074/jbc.M111.266940. Epub 2011 Nov 14.

8.

The miRNA-212/132 family regulates both cardiac hypertrophy and cardiomyocyte autophagy.

Ucar A, Gupta SK, Fiedler J, Erikci E, Kardasinski M, Batkai S, Dangwal S, Kumarswamy R, Bang C, Holzmann A, Remke J, Caprio M, Jentzsch C, Engelhardt S, Geisendorf S, Glas C, Hofmann TG, Nessling M, Richter K, Schiffer M, Carrier L, Napp LC, Bauersachs J, Chowdhury K, Thum T.

Nat Commun. 2012;3:1078. doi: 10.1038/ncomms2090.

9.

Overexpression of microRNA-99a Attenuates Cardiac Hypertrophy.

Li Q, Xie J, Wang B, Li R, Bai J, Ding L, Gu R, Wang L, Xu B.

PLoS One. 2016 Feb 25;11(2):e0148480. doi: 10.1371/journal.pone.0148480. eCollection 2016.

10.

MicroRNA-328 as a regulator of cardiac hypertrophy.

Li C, Li X, Gao X, Zhang R, Zhang Y, Liang H, Xu C, Du W, Zhang Y, Liu X, Ma N, Xu Z, Wang L, Chen X, Lu Y, Ju J, Yang B, Shan H.

Int J Cardiol. 2014 May 1;173(2):268-76. doi: 10.1016/j.ijcard.2014.02.035. Epub 2014 Feb 28.

PMID:
24631114
11.

miR-206 Mediates YAP-Induced Cardiac Hypertrophy and Survival.

Yang Y, Del Re DP, Nakano N, Sciarretta S, Zhai P, Park J, Sayed D, Shirakabe A, Matsushima S, Park Y, Tian B, Abdellatif M, Sadoshima J.

Circ Res. 2015 Oct 23;117(10):891-904. doi: 10.1161/CIRCRESAHA.115.306624. Epub 2015 Sep 2.

12.

Long Non-Coding RNA-ROR Mediates the Reprogramming in Cardiac Hypertrophy.

Jiang F, Zhou X, Huang J.

PLoS One. 2016 Apr 15;11(4):e0152767. doi: 10.1371/journal.pone.0152767. eCollection 2016.

13.

miR-106a promotes cardiac hypertrophy by targeting mitofusin 2.

Guan X, Wang L, Liu Z, Guo X, Jiang Y, Lu Y, Peng Y, Liu T, Yang B, Shan H, Zhang Y, Xu C.

J Mol Cell Cardiol. 2016 Oct;99:207-217. doi: 10.1016/j.yjmcc.2016.08.016. Epub 2016 Aug 23.

PMID:
27565029
14.

MiR-221 promotes cardiac hypertrophy in vitro through the modulation of p27 expression.

Wang C, Wang S, Zhao P, Wang X, Wang J, Wang Y, Song L, Zou Y, Hui R.

J Cell Biochem. 2012 Jun;113(6):2040-6. doi: 10.1002/jcb.24075.

PMID:
22275134
15.

MicroRNAs are aberrantly expressed in hypertrophic heart: do they play a role in cardiac hypertrophy?

Cheng Y, Ji R, Yue J, Yang J, Liu X, Chen H, Dean DB, Zhang C.

Am J Pathol. 2007 Jun;170(6):1831-40.

16.

miR-21-3p regulates cardiac hypertrophic response by targeting histone deacetylase-8.

Yan M, Chen C, Gong W, Yin Z, Zhou L, Chaugai S, Wang DW.

Cardiovasc Res. 2015 Mar 1;105(3):340-52. doi: 10.1093/cvr/cvu254. Epub 2014 Dec 10.

PMID:
25504627
17.

Thioredoxin 1 negatively regulates angiotensin II-induced cardiac hypertrophy through upregulation of miR-98/let-7.

Yang Y, Ago T, Zhai P, Abdellatif M, Sadoshima J.

Circ Res. 2011 Feb 4;108(3):305-13. doi: 10.1161/CIRCRESAHA.110.228437. Epub 2010 Dec 23.

18.

HMGA1 is a new target of miR-195 involving isoprenaline-induced cardiomyocyte hypertrophy.

You XY, Huang JH, Liu B, Liu SJ, Zhong Y, Liu SM.

Biochemistry (Mosc). 2014 Jun;79(6):538-44. doi: 10.1134/S0006297914060078.

PMID:
25100012
19.

Loss of MicroRNA-155 protects the heart from pathological cardiac hypertrophy.

Seok HY, Chen J, Kataoka M, Huang ZP, Ding J, Yan J, Hu X, Wang DZ.

Circ Res. 2014 May 9;114(10):1585-95. doi: 10.1161/CIRCRESAHA.114.303784. Epub 2014 Mar 21.

20.

MicroRNAs are dynamically regulated in hypertrophic hearts, and miR-199a is essential for the maintenance of cell size in cardiomyocytes.

Song XW, Li Q, Lin L, Wang XC, Li DF, Wang GK, Ren AJ, Wang YR, Qin YW, Yuan WJ, Jing Q.

J Cell Physiol. 2010 Nov;225(2):437-43. doi: 10.1002/jcp.22217.

PMID:
20458739

Supplemental Content

Support Center